SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
CeNeRx BioPharma, Inc. Announces FDA IND Approval for its Neuroprotective Agent in Chemotherapy-Induced Neuropathy and Results From First Human Study